Stocks › ANIP
ANI Pharmaceuticals Inc (ANIP) stock analysis
SKIP 8% confidence · analysed Sep 28, 2026
This analysis is from Sep 28, 2026 and may be out of date.
On Sep 28, 2026, our model rated ANI Pharmaceuticals Inc (ANIP) SKIP with 8% confidence at a price of $73.85. That means the signals cancel out; the model sees no clear edge either way.
Technical picture
The 14-day RSI is 60, showing healthy upward momentum without being stretched.
MACD is above its signal line, a sign that short-term momentum is turning up.
The price is below both its 50-day and 200-day moving averages, the classic picture of a downtrend.
Volume is only 0.1x its 20-day average; light trading makes the latest move less convincing.
Trend structure and money flow
Market structure: ranging / no clear structure.
The most recent swing high is $87.76 and the swing low is $70.15; traders often treat these as resistance and support.
Price is sitting in a bearish order block, a zone where large sellers stepped in before, so upside may stall here.
Fundamentals
The PEG ratio is 1.84, which looks reasonably priced for its growth.
The company reports a profit margin of 11.1% and revenue growth of +25.9%.
In its latest quarter it earned $2.21 per share, which beat the $2.04 analysts expected, with revenue +25.9% year over year.
Wall Street's average rating is 1.8 on a 1 (strong buy) to 5 (sell) scale, roughly a "buy", with an average price target of $105.78.
The next earnings report is expected around Nov 6, 2026; prices often move sharply around earnings.
The model's one-paragraph read
No clear edge (SKIP) — composite score +0.08 (SKIP). Technicals: RSI 60.36, MACD bullish, price below SMA50. Fundamentals: PEG 1.84, margin 11.1%, revenue growth 25.9%. Financial results: YoY revenue +25.9%, last EPS surprise +8.3%, next earnings 2026-11-06. Smart Money Concepts: ranging / no clear structure, price retesting a bearish order block. FinGPT news read: positive. Reference price $73.32; no trade levels (SKIP).
Past ratings for ANIP
| Date | Verdict | Confidence | Price | Move since | |
|---|---|---|---|---|---|
| Sep 28, 2026 | SKIP | 8% | $73.85 | — |
"Move since" compares each call's price with the latest analysed price.
Other Healthcare stocks we cover
ASTH · ATEC · ATRC · BCRX · BDX · BIIB · BMY · BSX · CNC · COO · CVS · DVA
Frequently asked questions
Is ANIP a buy right now?
As of Sep 28, 2026, our automated model rates ANI Pharmaceuticals Inc (ANIP) SKIP with 8% confidence: the signals cancel out; the model sees no clear edge either way. This is a model output for education, not personal investment advice.
When does ANI Pharmaceuticals Inc report earnings next?
The next earnings report is expected around Nov 6, 2026.
What does a SKIP rating mean?
A SKIP rating means the signals cancel out; the model sees no clear edge either way.
For information and education only. Not investment advice. Ratings are produced by an automated model, can be wrong, and may be out of date. Do your own research; you can lose money investing. The site's author may hold positions in stocks discussed here.